Hormel Foods through its incubator arm 199 Ventures has partnered with The Better Meat Co. to develop a process of making mycoprotein out of a potato-based fermentation.
The partnership would be tapping Better Meat’s technology in developing the process of creating the mycoprotein trade-named Rhiza.
Better Meat's process involves feeding potatoes to fungi, which in turn convert them into a “pale-colored, neutral-tasting ingredient” similar to chicken meat.
Founded in 1891, Minnesota-based Hormel has primarily been a meat company throughout much of its history, responsible for such meat products as Spam and Hormel Corned Beef.
But in recent years, Hormel has been shifting away from its “meat-centric reputation.”
Hormel CEO Jim Snee said in February that he soon expects at least 25 percent of their sales to come from non-meat products.
According to Fred Halvin, vice president of corporate development at Hormel Foods, with food culture changing rapidly, they would want to address the people's curiosity and willingness to try great tasting, plant-based proteins.
Halvin added that as a global branded food company, Hormel would want to offer delicious and convenient mycoprotein and plant-based protein products.
A Hormel spokesman said the company acknowledges that the alternative protein market has “a high growth trajectory.” He added Hormel Foods want to make sure that it to grow their product offerings in those categories.


Asian Chip Stocks Plunge as Bond Yields Fuel AI Valuation Fears
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Foreign U.S. Treasury Holdings Fall as Japan, UK and China Cut Positions
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Neuralink Expands Brain Implant Trials with 12 Global Patients
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
UK Wage Growth Holds at 3.5% as Unemployment Rises
Colombia Earthquake Losses Estimated at $9.58 Billion as Reconstruction Challenge Mounts
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Gold Prices Edge Higher as Dollar Weakens Ahead of Fed Minutes
Wall Street Slides as Treasury Yields Surge to 19-Year High
Stripe, Advent Reportedly Pursue $53 Billion PayPal Takeover
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Oil Prices Rise as US-Iran Tensions Renew Strait of Hormuz Supply Fears
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate 



